ESR2 and breast carcinoma: Recent studies have verified tissues ESR1 mutations in most tumor patients, especially with metastatic breast cancer, and some of them to activate the estrogen‐independent receptor,18, 39, 40 whereas ESR1 and ESR2 expression not only express in breast cancer but also have been shown in other cancer types.10, 15, 25, 42